0000886163-17-000033.txt : 20170228
0000886163-17-000033.hdr.sgml : 20170228
20170228203040
ACCESSION NUMBER: 0000886163-17-000033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170227
FILED AS OF DATE: 20170228
DATE AS OF CHANGE: 20170228
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aryeh Jason
CENTRAL INDEX KEY: 0001376960
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 17651000
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2017-02-27
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001376960
Aryeh Jason
3911 SORRENTO VALLEY BOULEVARD, STE 110
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2017-02-27
4
S
0
25000
106.0
D
160898
I
Indirect
Common Stock
2017-02-28
4
S
0
7000
107.58
D
153898
I
Indirect
Common Stock
58959
D
Common Stock
5025
I
by Trust
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.99 to $106.99, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
All securities disclosed in this Form 4 are owned by certain funds managed by JALAA Equities, LP, JLV Investments, LP and affiliates (the "Funds"). Jason Aryeh is the General Partner of JALAA Equities, LP and a partner of JLV Investments, LP. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, JALAA Equities, LP, JLV Investments, LP and affiliates and Mr. Aryeh may be deemed to be the beneficial owners of the securities beneficially owned by the Funds.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.49 to $107.94, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
By: Charles S. Berkman For: Jason Aryeh
2017-02-28